Age Ayurveda Nighantu

Kshirabala Thailam

Kshirabala Thailam is a classical Ayurvedic taila, a medicated oil. Listed in Ayurvedic Formulary of India (AFI). Ashtanga Hridayam (Vatarakta Chikitsa chapter). The 101 Avarti (101 times processed) variant is described in Sahasrayogam.

Key facts
Also known asKshirabala Thailam, KshirabalaThailam
Pharmacopoeia statusListed in Ayurvedic Formulary of India (AFI). Referenced in Ashtanga Hridayam and Sahasrayogam. The 101 Avarti form is a speciality product unique to the Kerala Ayurvedic tradition. Manufactured by major Ayurvedic companies (Kottakkal, Kerala Ayurveda, Vaidyaratnam) under GMP standards.

Names and identification

LanguageName
EnglishKshirabala Thailam

Where is it described in the classical texts?

Ashtanga Hridayam (Vatarakta Chikitsa chapter). The 101 Avarti (101 times processed) variant is described in Sahasrayogam. One of the most referenced Tailas in Kerala Ayurvedic tradition.

How does it work?

  • Ephedrine and pseudoephedrine alkaloids from Bala (Sida cordifolia) provide analgesic, anti-inflammatory, and bronchodilatory effects via adrenergic receptor modulation
  • Repeated processing (101 Avarti) concentrates lipophilic phytoconstituents and increases bioavailability of low molecular weight fatty acids facilitating transdermal and transmucosal absorption
  • Milk proteins and fats act as emulsifiers that stabilize herbal extracts and enhance penetration through biological membranes, including nasal mucosa during Nasya administration
  • Beta-sitosterol and mucilaginous compounds from Bala nourish nerve tissue (Majja Dhatu) and strengthen neuromuscular junctions

Which traditional uses are supported by research?

  • Neurological disorders (facial paralysis, hemiplegia, sciatica) - validated by clinical studies showing neuroprotective activity and motor function improvement
  • Cervical and lumbar spondylosis - supported by randomized trials demonstrating significant pain and stiffness reduction comparable to conventional treatment
  • Insomnia and anxiety (Vata-related mental disorders) - supported by the nervine tonic and GABA-modulatory properties of Bala alkaloids confirmed in pharmacological studies

What do recent clinical trials show?

3 further claims previously listed here could not be traced to a published paper and have been removed. Classical formulations are researched largely in journals that PubMed does not index, so an absence here reflects the reach of the index rather than the state of the evidence.

Recent safety updates

  • No serious side effects reported with internal or external use. High oral doses may cause mild digestive discomfort in some individuals. Rare cases of skin allergy have been noted - patch test advised for sensitive individuals.
  • Safe for use in children and elderly under practitioner guidance. Contraindicated in Kapha-dominant conditions with excessive congestion. Those with lactose intolerance may need to exercise caution with internal use given the milk component.

What is it made of?

Key Active Markers

  • Derived from constituent herbs (see individual herb profiles)
  • Standardized on primary bioactive markers

Analytical Methods: HPLC fingerprinting, TLC (identity), LC-MS/MS (marker quantification)

Dosage forms and preparation

Dosage Forms: Thailam (medicated oil for external/internal use), Capsules (modern), Nasal drops (for Nasya)

Standard Dosage: External: sufficient for Abhyanga. Internal: 5-15 mL with warm milk. Nasya: 2-6 drops per nostril. As per Sahasrayogam/AFI

Bioavailability: Oil-milk processing creates unique liposomal-like phospholipid complexes enhancing dermal and mucosal absorption. Multi-avartana processing concentrates actives — 101 avartana oil is significantly more potent per drop. Nasya route provides direct CNS access. Internal use provides systemic distribution via lipid absorption pathway.

Optimal Timing: External: morning Abhyanga. Internal: before meals or bedtime. Nasya: morning on empty stomach.

Shelf Life: 3 years from date of manufacture. Multi-avartana versions may have longer practical shelf life.

Storage: Store in amber glass bottles in a cool, dry place. Temperature not exceeding 25°C. Protect from light. Nasya variant requires enhanced microbial standards.

Marker Compounds: Ephedrine, Pseudoephedrine, Beta-sitosterol, Sesamin, Sesamolin, Phospholipid complexes (from milk processing)

Quality Parameters: Acid value (<5), peroxide value (<10), saponification value, refractive index, specific gravity, viscosity (increases with avartana number), HPTLC fingerprint (band intensity increases with avartana), ephedrine equivalents, total alkaloids, microbial limits (strict for Nasya variant), heavy metals

Vehicle (Anupana): External: warm oil. Internal: warm milk. Nasya: lukewarm oil.

Synergistic Combinations

Composition

As given in the Ayurvedic Formulary of India, Part I, entry 8:11 (KSIRABALA TAILA), which cites Astangahrdaya, Vataraktacikitsa, Adhyaya 22; 44.. Names, parts and quantities are transcribed as printed and checked row by row against the book. Manufacturers' versions of a classical formulation can differ from the formulary.

#IngredientPartQuantity
1Bala kasaya (bala) (bala)root16 parts
2Bala kalka (bala) (bala)root1 part
3Taila (tila) (tila)oil4 parts
4Ksira (godugdha) (godugdha)4 parts
5Water16 parts

Source scan of the formulary

Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.

Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.